Europe Drug Discovery Outsourcing Market Size & Outlook
Global Market
Related Markets
Europe drug discovery outsourcing market highlights
- The Europe drug discovery outsourcing market generated a revenue of USD 2,202.2 million in 2025.
- The market is expected to grow at a CAGR of 10.1% from 2026 to 2033.
- In terms of segment, lead identification & candidate optimization was the largest revenue generating workflow in 2025.
- Other Associated Workflow is the most lucrative workflow segment registering the fastest growth during the forecast period.
- Country-wise, Italy is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 2,202.2 million |
| Market revenue in 2033 | USD 4,702.4 million |
| Growth rate | 10.1% (CAGR from 2026 to 2033) |
| Largest segment | Lead identification & candidate optimization |
| Fastest growing segment | Other Associated Workflow |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, Other Associated Workflow |
| Key market players worldwide | Albany Molecular Research, Evotec SE, Labcorp Holdings Inc, GenScript ProBio, Pharmaceutical Product Development, Charles River Laboratories International Inc, Wuxi AppTec Co Ltd, Merck & Co Inc, Thermo Fisher Scientific Inc, Dalton Pharma Services, Jubilant Biosys, Qiagen NV, Eurofins Scientific SE, Dr. Reddy’s Laboratories, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, TCG Lifesciences, Syngene, Oncodesign, DiscoveRX, Domainex |
Other key industry trends
- In terms of revenue, Europe region accounted for 27.3% of the global drug discovery outsourcing market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,210.0 million by 2033.
While the European drug market appears to be shrinking, the BRIC economies are continuously experiencing higher sales growth. The total pharmaceutical sales of BRIC countries were expected to grow at a rate of 15% per year from 2011 to 2016 and the sales in the European countries (i.e. Germany, France, Italy, United Kingdom, and Spain) were expected to drop at a rate of 1.2% over the same period.
According to a study, total pharma spending of EU has decreased from 17% in 2011 to 13% of the global market in 2016, still it is expected that EU market will continue to be a major source of revenue for branded pharmaceutical companies.
EU has taken initiatives in various projects and is discovering and developing various drugs including antibiotic drugs to increase the growth of drug discovery services within the country.
No credit card required*
Publish Date: Jul 23, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Drug Discovery Outsourcing Market Scope
Drug Discovery Outsourcing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Eurofins Scientific SE | View profile | 61,798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | www.eurofins.com |
| Charles River Laboratories International Inc | View profile | 21,400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | www.criver.com |
| Merck & Co Inc | View profile | 72,000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | www.merck.com |
| Labcorp Holdings Inc | View profile | 67,000 | 358 South Main Street, Burlington, NC, United States, 27215 | www.labcorp.com |
| Dr. Reddy’s Laboratories | View profile | 10001+ | Hyderabad, Andhra Pradesh, India, Asia | www.drreddys.com/ |
| Wuxi AppTec Co Ltd | View profile | 41,116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | www.wuxiapptec.com |
| Evotec SE | View profile | 5,055 | Essener Bogen 7, Manfred Eigen Campus, Hamburg, Germany, 22419 | www.evotec.com |
| GenScript ProBio | View profile | 1001-5000 | Nanjing, Jiangsu, China, Asia | www.genscriptprobio.cn |
Europe Drug Discovery Outsourcing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Drug Discovery Outsourcing Market Outlook will help companies and investors design strategic landscapes.
Lead Identification & Candidate Optimization was the largest segment with a revenue share of 34.91% in 2025.
Horizon Databook has segmented the Europe drug discovery outsourcing market based on target identification & screening, target validation & functional informatics, lead identification & candidate optimization, preclinical development, other associated workflow covering the revenue growth of each sub-segment from 2021 to 2033.
While the European drug market appears to be shrinking, the BRIC economies are continuously experiencing higher sales growth. The total pharmaceutical sales of BRIC countries were expected to grow at a rate of 15% per year from 2011 to 2016 and the sales in the European countries (i.e. Germany, France, Italy, United Kingdom, and Spain) were expected to drop at a rate of 1.2% over the same period.
According to a study, total pharma spending of EU has decreased from 17% in 2011 to 13% of the global market in 2016, still it is expected that EU market will continue to be a major source of revenue for branded pharmaceutical companies.
EU has taken initiatives in various projects and is discovering and developing various drugs including antibiotic drugs to increase the growth of drug discovery services within the country.
- Europe Drug Discovery Outsourcing Market Workflow Outlook (Revenue, USD Million , 2021-2033)
- Target Identification & Screening
- Target Validation & Functional Informatics
- Lead Identification & Candidate Optimization
- Preclinical Development
- Other Associated Workflow
- Europe Drug Discovery Outsourcing Market Molecule Outlook (Revenue, USD Million , 2021-2033)
- Small Molecules
- Large Molecules
- Europe Drug Discovery Outsourcing Market Service Outlook (Revenue, USD Million , 2021-2033)
- Chemistry Services
- Biology Services
- Europe Drug Discovery Outsourcing Market Therapeutics Area Outlook (Revenue, USD Million , 2021-2033)
- Respiratory system
- Pain and Anesthesia
- Oncology
- Ophthalmology
- Hematology
- Cardiovascular
- Endocrine
- Gastrointestinal
- Immunomodulation
- Anti-infective
- Central Nervous System
- Dermatology
- Genitourinary System
- Others
- Europe Drug Discovery Outsourcing Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Pharmaceutical & Biotechnology companies
- Academic Institutes
Reasons to subscribe to Drug Discovery Outsourcing Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Drug Discovery Outsourcing Market Outlook databook
- Our clientele includes a mix of Drug Discovery Outsourcing Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Drug Discovery Outsourcing Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Drug Discovery Outsourcing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Drug Discovery Outsourcing Market, 2021-2033 (US$M)
Europe Workflow - Drug Discovery Outsourcing Market Statistics, 2025 - 2033 (US$M)
